New Ray Medicine International Holding Limited (06108.HK)

New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. The company is headquartered in Hangzhou, Zhejiang and currently employs 30 full-time employees. The company went IPO on 2013-10-25. The firm operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The firm mainly operates its businesses in the domestic market.